Category: Neurological
Neurological
NeuroMetrix Inc. posted fourth-quarter profits of $363,000, due to a $2.2 million revaluation of warrants last year, but full-year 2009 profits still elude the nerve conduction test equipment maker.
A revaluation of warrants and a change in reimbursement policy helped produce fourth-quarter profits and hope for future top-line growth for NeuroMetrix Inc. (NSDQ:NURO).
Micrus Endovascular Corp. posted a profitable third quarter and a 24 percent increase in Q3 revenues.
Micrus Endovascular Corp. (NSDQ:MEND) posted third-quarter sales of $22.8 million for the three months ended Dec. 31, 2009, up 24.4 percent compared with $18.3 million during the same period in 2008. The company swung from a net loss of $2.3 million during Q3 2009 to net income of $3.3 million during Q3 2010:
Press Release
Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20
Record Quarterly Revenues up 24%; Double-digit Revenue Growth in All Major Geographic Regions; Fourth Consecutive Quarter of Profitability
A judge in the U.S. District Court for Massachusetts dismissed a shareholders' lawsuit accusing NeuroMetrix Inc. of misleading investors about the prospects for reimbursement for its NC-Stat device.
A federal judge in Boston dismissed a lawsuit filed against NeuroMetrix Inc. (NSDQ:NURO) by shareholders accusing the company and its management of misleading them over reimbursement for its NC-Stat device.
Judge Rya Zobel of the U.S. District Court for Massachusetts ruled that the plaintiffs, the pension fund of the IBEW-NECA electrical workers' union, failed to establish that NeuroMetrix and its then-management team misled investors in quarterly regulatory filings and in conference calls with analysts discussing quarterly results.
A wireless brain-machine interface allows a patient with locked-in syndrome to speak vowels; "Bronchial GPS" lung navigation; a urine check for pneumonia; and an off-road wheelchair.
Wireless brain-computer link returns vowels to paralyzed man: Locked-In Syndrome, which leaves patients aware but almost entirely without the power to move, is one of the most terrifying potential results of brain lesions. Now, a collaboration of American researchers has implanted a wireless brain-machine interface, developed by Neural Signals of Duluth, Ga., into a locked-in subject who is almost completely paralyzed. The system uses brain electrodes to read signals meant for jaw and mouth muscles. An FM radio is used to transmit these brain signals to a computer, which transforms them into recognizable sounds.
Aspect Medical Systems accepts a tender offer for $58 million worth of senior notes as part of Covidien's $210 million acquisition.
Aspect Medical Systems (NSDQ:ASPM) accepted Covidien's (NYSE:COV) $58 million tender offer on a portion of Aspect's debt as part of a $210 million acquisition.
The offer for the 2.5 percent convertible senior notes, which come due in 2014, expired Dec. 11, 2009. Holders of the $57.95 million worth of notes will get $1,012.43 per $1,000 invested, making the aggregate cost of the buy about $58.7 million. Covidien said the payout includes accrued interest on the notes up to but not including the date of payment.
Three years after purchasing Confluent Surgical for $245 million, the medical device colossus launches the DuraSeal Spine Sealant in the U.S.
It took seven years and a $245 million merger, but the DuraSeal Spine Sealant finally hit the market in the U.S.
